Company Cash Funds: Petros Pharmaceuticals, Inc. (PTPI)

Public company logo of petrospharma.com (PTPI)

Changes in cash and cash equivalents clearly demonstrate liquidity dynamics, where the 0.00 mark serves as a key metric. Stable pharmacy sales are supported by the habits of patients monetizing men's health products. This reinforces the pricing power of Stendra amid low demand elasticity. Currently, Petros Pharmaceuticals (PTPI) is executing a strategic pivot, developing IT services to transition prescription drugs into the over-the-counter consumer goods segment.

Petros - PTPI Company Cash Balance (period 07/04/2022 - 06/28/2025)

Financial and market metric breakdowns for Petros Pharmaceuticals, Inc. (PTPI)

- company stock exchange capitalization indicators:
Comprehensive company analysis:PTPI Petros Pharmaceuticals
Brand item of petrospharma.com

Petros Pharmaceuticals (PTPI) is facing a liquidity shortage as operating expenses outweigh revenue. This indicator measures the daily rate of capital depletion or accumulation, determining the issuer's financial stability. By analyzing cash flow dynamics, an investor can see the actual burn rate. While growing reserves reduce default risk, they may signal investment stagnation. The current state confirms the business's dependence on external financing.

Direct competitors

Company Cash Funds Haleon (HLN)|Company Cash Volume Kenvue Inc. (KVUE)|Company Cash Volume VRNA (veronapharma.com)|Company Cash Balance MENS|LGND: Company Cash on Hand|Company Cash Balance AMRX (Amneal Corp)|PRGO (Perrigo Company plc) - Company Cash on Hand|Alvotech - Company Cash Balance|Company Cash on Hand LQDA|Galapagos Genomics (GLPG) - Company Liquid Assets|Company Cash Volume ANIP|Company Cash on Hand Afrezza MNKD|Company Cash Funds Amphastar AMPH|Company Liquid Assets Pacira BioSciences (PCRX)|ARS Corp - Company Cash Volume|TBPH: Company Cash Funds|AQST: Company Cash Volume|SCPH - Company Liquid Assets|TECX (Tectonic) - Company Cash Volume|Company Cash Reserve Tonix Pharmaceuticals Holding Corp. TNXP|Company Cash Funds SXT Pharmaceuticals (SXTC)|Company Cash Volume Eupraxia Pharmaceuticals Inc. (EPRX)|Company Cash Funds BioHarvest Sciences BHST|EXOZ (Invizyne) - Company Total Cash Volume|ORMP: Company Cash on Hand|ENTX (Entera Bio Ltd) - Company Cash and Cash Equivalents|HYFT: Company Cash Volume|Company Cash on Hand ABVC BioPharma Inc.|CPIX (cumberlandpharma.com) - Company Cash Volume|Company Cash Funds QNTM|Company Cash Volume FGEN|Company Cash on Hand Telomir Pharmaceuticals TELO|Company Cash Volume RANI (ranitherapeutics.com)|SNYR (Synergy CHC Corporation) - Company Total Cash Volume|RLYB - Company Cash Funds|LEXX (Lexaria Bioscience Corp.) - Company Cash and Cash Equivalents|pulmatrix.com (PULM) - Company Cash Funds|PTHL (Pheton) - Company Cash Funds|Company Cash Funds Aptorum|Company Cash Reserve Lyra Therapeutics Inc. LYRA|Company Cash Volume IBO|TNFA (TNF Pharmaceuticals, Inc.) - Company Cash Balance|Company Cash Funds cbdMD, Inc. YCBD|Company Cash Balance PRFX|Altamira Therapeutics Ltd. - Company Cash Volume|Company Cash Reserve Lipella Pharmaceuticals Inc|OPTN: Company Cash Volume|Pieris - Company Cash Balance|Company Cash on Hand PROC|QLI: Company Cash Balance|Company Cash Volume SLRN|TFFP (TFF Pharmaceuticals Inc.) - Company Cash Balance